Abstract
The issue number is given in front of the pagination
Aarsland, D., see Alghamdi, A. (2) 373–386
Aarsland, D., see Bloniecki, V. (2) 387–393
Aarsland, D., see Kramberger, M.G. (3) 787–795
Abdelnour, C., O. Rodríguez-Gómez, M. Alegret, S. Valero, S. Moreno-Grau, Á. Sanabria, I. Hernández, M. Rosende-Roca, L. Vargas, A. Mauleón, D. Sánchez, A. Espinosa, G. Ortega, A. Pérez-Cordón, S. Diego, A. Gailhajanet, M. Guitart, Ó. Sotolongo-Grau, A. Ruiz, L. Tárraga and M. Boada, Impact of Recruitment Methods in Subjective Cognitive Decline (2) 625–632
Abdelnour, C., see Kramberger, M.G. (3) 787–795
Aizenstein, H., see O’Hare, C. (4) 1239–1250
Alberici, A., see Gazzina, S. (4) 1185–1189
Albert, M.S., see Hane, F.T. (3) 645–665
Albuisson, E., see Gervaise-Henry, C. (2) 437–445
Alegret, M., see Abdelnour, C. (2) 625–632
Alegret, M., see Espinosa, A. (2) 447–459
Alfini, A.J., see Chirles, T.J. (3) 845–856
Alghamdi, A., J. Vallortigara, D.R. Howlett, M. Broadstock, T. Hortobágyi, C. Ballard, A.J. Thomas, J.T. O’Brien, D. Aarsland, J. Attems, P.T. Francis and D.R. Whitfield, Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia (2) 373–386
Ally, B.A., see Mason, E.J. (3) 735–745
Alosco, M.L., J. Duskin, L.M. Besser, B. Martin, C.E. Chaisson, J. Gunstad, N.W. Kowall, A.C. McKee, R.A. Stern and Y. Tripodis, Modeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer’s Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer’s Coordinating Center Data Set (3) 953–968
Amador, C., see Marioni, R.E. (1) 275–283
Ambasta, R.K., see Jha, S.K. (4) 1017–1039
Amen, D.G., P. Krishnamani, S. Meysami, A. Newberg and C.A. Raji, Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging (1) 253–266
Ames, D., see Hollands, S. (2) 411–422
Andrews, H., see Zhu, C.W. (1) 305–315
Andrews, S.J., D. Das, K.J. Anstey and S. Easteal, Late Onset Alzheimer’s Disease Risk Variants in Cognitive Decline: The PATH Through Life Study (2) 423–436
Anstey, K.J., R. Eramudugolla, S. Chopra, J. Price and J.M. Wood, Assessment of Driving Safety in Older Adults with Mild Cognitive Impairment (4) 1197–1205
Anstey, K.J., see Andrews, S.J. (2) 423–436
Antoine, P., see El Haj, M., (1) 285–291
Arbizu, J., see Espinosa, A. (2) 447–459
Archetti, S., see Gazzina, S. (4) 1185–1189
Argimon, J.M., see Reed, C. (3) 797–812
Arnhard, K., see Oberacher, H. (2) 493–504
Arrighi, H.M., see Ketter, N., (2) 557–573
Artacho-Pérula, E., see Delgado-González, J.-C. (2) 461–473
Atalla, S.W., see Monroe, T.B. (1) 71–83
Attems, J., see Alghamdi, A. (2) 373–386
Auestad, B., see Kramberger, M.G. (3) 787–795
Auguste, N., see Rouch, I. (1) 147–155
Augustinack, J.C., see Lindemer, E.R. (1) 293–303
Bagnoli, S., see Lombardi, G. (3) 697–703
Bai, O., see Hane, F.T. (3) 645–665
Bai, X.-Q., see Liu, L.-S. (3) 723–734
Baker, L.D., see Craft, S. (4) 1325–1334
Balietti, M., C. Giuli, P. Fattoretti, P. Fabbietti, R. Papa, D. Postacchini and F. Conti, Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer’s Disease (1) 37–43
Ballard, C., see Alghamdi, A. (2) 373–386
Bamji-Mirza, M., see Dorey, E. (4) 1265–1279
Banks, W.A., see Rhea, E.M. (1) 241–252
Banzo, I., see Riancho, J. (3) 717–721
Barkhof, F., see Ketter, N., (2) 557–573
Barocco, F., M. Spallazzi, L. Concari, S. Gardini, A. Pelosi and P. Caffarra, The Progression of Alzheimer’s Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up (3) 775–786
Barshatzky, M., see Mehta, P.D. (1) 135–145
Beach, P.A., see Monroe, T.B. (1) 71–83
Becker, J.T., see Espinosa, A. (2) 447–459
Beeg, M., see Romeo, M. (3) 857–871
Belger, M., see Reed, C. (3) 797–812
Benke, T., see Sanin, G. (1) 53–59
Benninghoff, J., see van der Ven, A.T. (2) 531–540
Berti, V., see Lombardi, G. (3) 697–703
Besser, L.M., see Alosco, M.L. (3) 953–968
Bethea, C.L., A.P. Reddy and F.L. Christian, How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer’s Disease (4) 1001–1015
Beydoun, H.A., see Beydoun, M.A. (3) 813–824
Beydoun, M.A., A.A. Gamaldo, H.A. Beydoun, D. Shaked, A.B. Zonderman and S.M. Eid, Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer’s Disease with at Least One Procedure: The Nationwide Inpatient Sample (3) 813–824
Bhaskar, K., see Jiang, S. (4) 1123–1135
Biessels, G.J., see Bouvy, W.H. (3) 705–710
Biundo, R., see Kramberger, M.G. (3) 787–795
Blain, J.-F., see Mehta, P.D. (1) 135–145
Blanc, F., see Kramberger, M.G. (3) 787–795
Blennow, K., see Bloniecki, V. (2) 387–393
Blennow, K., see Lopez-Font, I. (4) 1281–1291
Bloniecki, V., D. Aarsland, K. Blennow, J. Cummings, F. Falahati, B. Winblad and Y. Freund-Levi, Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid (2) 387–393
Blumberger, D.M., see Isserles, M. (1) 45–51
Boa Sorte Silva, N.C., see Gregory, M.A. (3) 747–763
Boada, M., see Abdelnour, C. (2) 625–632
Boada, M., see Espinosa, A. (2) 447–459
Bogert, J., see Ketter, N., (2) 557–573
Boix, C.P., see Lopez-Font, I. (4) 1281–1291
Bonanni, L., see Kramberger, M.G. (3) 787–795
Bonomi, E., see Gazzina, S. (4) 1185–1189
Borroni, B., see Gazzina, S. (4) 1185–1189
Bos, D., see Wingbermühle, R. (4) 1191–1195
Bostantjopoulou, S., see Kramberger, M.G. (3) 787–795
Boudreau, R., see O’Hare, C. (4) 1239–1250
Bouvy, W.H., H.J. Kuijf, J.J.M. Zwanenburg, H.L. Koek, L.J. Kappelle, P.R. Luijten, M.K. Ikram and G.J. Biessels on behalf of the Utrecht Vascular Cognitive Impairment (VCI) Study group, Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer’s Disease: A Pilot Study (3) 705–710
Bouzrou, M., see Rüb, U. (3) 683–696
Brashear, H.R., see Ketter, N., (2) 557–573
Bravo, M., see Riancho, J. (2) 483–491
Broadstock, M., see Alghamdi, A. (2) 373–386
Brueggen, K., E. Kasper, S. Ochmann, H. Pfaff, S. Webel, W. Schneider and S. Teipel, Cognitive Rehabilitation in Alzheimer’s Disease: A Controlled Intervention Trial (4) 1315–1324
Bruehl, S.P., see Monroe, T.B. (1) 71–83
Bruno, G., see Reed, C. (3) 797–812
Buendía, M., see Espinosa, A. (2) 447–459
Bush, A.I., see Cardoso, B.R. (1) 183–193
Cabrera-Martín, M.N., see Fernández-Matarrubia, M. (4) 1251–1264
Caffarra, P., see Barocco, F. (3) 775–786
Cagnotto, A., see Romeo, M. (3) 857–871
Cai, Q. and P. Tammineni, Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer’s Disease (4) 1087–1103
Calero, M., see Riancho, J. (2) 483–491
Callaghan, D., see Dorey, E. (4) 1265–1279
Callahan, B.L., see Dallaire-Théroux, C. (2) 575–601
Calvo-Simal, S., see García-Casal, J.A. (3) 937–951
Campbell, A., see Marioni, R.E. (1) 275–283
Cardoso, B.R., D.J. Hare, A.I. Bush, Q.-X. Li, C.J. Fowler, C.L. Masters, R.N. Martins, K. Ganio, A. Lothian, S. Mukherjee, E.A. Kapp, B.R. Roberts and The AIBL research group, Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer’s Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) (1) 183–193
Carreras, J.L., see Fernández-Matarrubia, M. (4) 1251–1264
Carril, J.M., see Riancho, J. (3) 717–721
Caulder, E., see Craft, S. (4) 1325–1334
Cavallo, F., see D’Onofrio, G. (3) 927–935
Chaisson, C.E., see Alosco, M.L. (3) 953–968
Charlesworth, G., see Stott, J. (4) 1293–1302
Chen, C., see Wei, M. (3) 899–906
Cheng, B., see Huang, Y. (3) 885–897
Cheng, X., see Wang, J. (1) 227–240
Chirles, T.J., K. Reiter, L.R. Weiss, A.J. Alfini, K.A. Nielson and J.C. Smith, Exercise Training and Functional Connectivity Changes in Mild Cognitive Impairment and Healthy Elders (3) 845–856
Cho, H., see Kim, H.J. (3) 711–716
Cho, Y.S., see Kim, H.J. (3) 711–716
Choi, J.Y., see Kim, H.J. (3) 711–716
Cholerton, B., see Craft, S. (4) 1325–1334
Chong, M.S., see Rawtaer, I. (2) 603–611
Chopra, S., see Anstey, K.J. (4) 1197–1205
Christian, F.L., see Bethea, C.L. (4) 1001–1015
Cintron, A.F., see Heuer, E. (2) 519–530
Claxton, A., see Craft, S. (4) 1325–1334
Cobelli, C., see Pievani, M. (3) 825–843
Concari, L., see Barocco, F. (3) 775–786
Conti, F., see Balietti, M. (1) 37–43
Corbelli, A., see Romeo, M. (3) 857–871
Cosentino, S., see Zhu, C.W. (1) 305–315
Cosseddu, M., see Gazzina, S. (4) 1185–1189
Cotelli, M., see Pievani, M. (3) 825–843
Cowan, R.L., see Monroe, T.B. (1) 71–83
Craft, S., A. Claxton, L.D. Baker, A.J. Hanson, B. Cholerton, E.H. Trittschuh, D. Dahl, E. Caulder, B. Neth, T.J. Montine, Y. Jung, J. Maldjian, C. Whitlow and S. Friedman, Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial (4) 1325–1334
Cummings, J., see Bloniecki, V. (2) 387–393
Curiel, R.E., see Czaja, S.J. (4) 1229–1238
Czaja, S.J., D.A. Loewenstein, S.A. Sabbag, R.E. Curiel, E. Crocco and P.D. Harvey, A Novel Method for Direct Assessment of Everyday Competence Among Older Adults (4) 1229–1238
D’Onofrio, G., D. Sancarlo, F. Ricciardi, F. Panza, D. Seripa, F. Cavallo, F. Giuliani and A. Greco, Information and Communication Technologies for the Activities of Daily Living in Older Patients with Dementia: A Systematic Review (3) 927–935
Dahl, D., see Craft, S. (4) 1325–1334
Dallaire-Théroux, C., B.L. Callahan, O. Potvin, S. Saikali and S. Duchesne, Radiological-Pathological Correlation in Alzheimer’s Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings (2) 575–601
Dang, L., see Wei, M. (3) 899–906
Das, D., see Andrews, S.J. (2) 423–436
Daskalakis, Z.J., see Isserles, M. (1) 45–51
de Jong, F.J., see Kramberger, M.G. (3) 787–795
de la Torre, J.C., Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations (2) 353–371
de la Torre, R., see Fenoll, R. (1) 61–70
De Marco, M., D. Duzzi, F. Meneghello and A. Venneri, Cognitive Efficiency in Alzheimer’s Disease is Associated with Increased Occipital Connectivity (2) 541–556
de Sola, S., see Fenoll, R. (1) 61–70
Deal, J.A., see Meyer, M.L. (1) 195–204
Deary, I.J., see Marioni, R.E. (1) 275–283
Delgado-González, J.-C., J. Florensa-Vila, F. Mansilla-Legorburo, R. Insausti and E. Artacho-Pérula, Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer’s Disease Subjects (2) 461–473
Deng, Y., see Wei, M. (3) 899–906
Deus, J., see Fenoll, R. (1) 61–70
Di Lorenzo, D., see Gazzina, S. (4) 1185–1189
Di, J., see Ketter, N., (2) 557–573
Diego, S., see Abdelnour, C. (2) 625–632
Dierssen, M., see Fenoll, R. (1) 61–70
Dietrich, M.S., see Monroe, T.B. (1) 71–83
Diomede, L., see Romeo, M. (3) 857–871
Diwo, A., see Oberacher, H. (2) 493–504
Dodel, R., see Reed, C. (3) 797–812
Donahue, M.J., see Mason, E.J. (3) 735–745
Dong, J., W. Qin, C. Wei, Y. Tang, Q. Wang and J. Jia, A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer’s Disease Affects Amyloid-β Production and Tau Phosphorylation (2) 613–623
Dong, Y., see Zhang, C. (2) 505–518
Dooyema, J., see Heuer, E. (2) 519–530
Dorey, E., M. Bamji-Mirza, D. Najem, Y. Li, H. Liu, D. Callaghan, D. Walker, L.-F. Lue, D. Stanimirovic and W. Zhang, Apolipoprotein E Isoforms Differentially Regulate Alzheimer’s Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro (4) 1265–1279
Dorey, J.-M., see Rouch, I. (1) 147–155
Dousset, B., see Gervaise-Henry, C. (2) 437–445
Du, H., see Guo, L. (4) 1071–1086
Du, R., see Heuer, E. (2) 519–530
Duchesne, S., see Dallaire-Théroux, C. (2) 575–601
Duskin, J., see Alosco, M.L. (3) 953–968
Duzzi, D., see De Marco, M. (2) 541–556
Dyrba, M., see Ochmann, S. (4) 1303–1313
Easteal, S., see Andrews, S.J. (2) 423–436
Eid, S.M., see Beydoun, M.A. (3) 813–824
El Haj, M., K. Gallouj and P. Antoine, Google Calendar Enhances Prospective Memory in Alzheimer’s Disease: A Case Report (1) 285–291
Eramudugolla, R., see Anstey, K.J. (4) 1197–1205
Espinosa, A., M. Alegret, P. Pesini, S. Valero, A. Lafuente, M. Buendía, I.S. José, M. Ibarria, M.A. Tejero, J. Giménez, S. Ruiz, I. Hernández, F. Pujadas, P. Martínez-Lage, J. Munuera, J. Arbizu, L. Tárraga, S.B. Hendrix, A. Ruiz, J.T. Becker, S.M. Landau, O. Sotolongo-Grau, M. Sarasa and M. Boada, for the AB255 Study Group, for the Alzheimer’s Disease Neuroimaging Initiative, Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype (2) 447–459
Espinosa, A., see Abdelnour, C. (2) 625–632
Esquerda-Canals, G., L. Montoliu-Gaya, J. Güell-Bosch and S. Villegas, Mouse Models of Alzheimer’s Disease (4) 1171–1183
Esteba-Castillo, S., see Fenoll, R. (1) 61–70
Eustace, J., see O’Caoimh, R. (1) 123–133
Fabbietti, P., see Balietti, M. (1) 37–43
Fabre, F., see Rouch, I. (1) 147–155
Falahati, F., see Bloniecki, V. (2) 387–393
Falup-Pecurariu, C., see Kramberger, M.G. (3) 787–795
Farr, S.A., see Rhea, E.M. (1) 241–252
Fattoretti, P., see Balietti, M. (1) 37–43
Federico, D., see Rouch, I. (1) 147–155
Feng, L., see Rawtaer, I. (2) 603–611
Feng, N., see Yin, H. (4) 1207–1220
Fenoll, R., J. Pujol, S. Esteba-Castillo, S. de Sola, N. Ribas-Vidal, J. García-Alba, G. Sánchez-Benavides, G. Martínez-Vilavella, J. Deus, M. Dierssen, R. Novell-Alsina and R. de la Torre, Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients (1) 61–70
Fernández-Matarrubia, M., J.A. Matías-Guiu, M.N. Cabrera-Martín, T. Moreno-Ramos, M. Valles-Salgado, J.L. Carreras and J. Matías-Guiu, Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study (4) 1251–1264
Ferrari, C., see Lombardi, G. (3) 697–703
Ferrari, C., see Pievani, M. (3) 825–843
Fiordaliso, F., see Romeo, M. (3) 857–871
Fischer, N., see van der Ven, A.T. (2) 531–540
Fischl, B., see Lindemer, E.R. (1) 293–303
Florensa-Vila, J., see Delgado-González, J.-C. (2) 461–473
Fowler, C., see Hollands, S. (2) 411–422
Fowler, C.J., see Cardoso, B.R. (1) 183–193
Frackowiak, J., see Mehta, P.D. (1) 135–145
Francis, P.T., see Alghamdi, A. (2) 373–386
Franco-Martín, M., see García-Casal, J.A. (3) 937–951
Freeman, E.A., see Mehta, P.D. (1) 135–145
Freulon, M., see Rouch, I. (1) 147–155
Freund-Levi, Y., see Bloniecki, V. (2) 387–393
Friedman, S., see Craft, S. (4) 1325–1334
Frisoni, G.B., see Pievani, M. (3) 825–843
Fu, M., see Lambracht-Washington, D. (1) 97–112
Fukuhara, R., see Shinagawa, S. (4) 1221–1227
Gailhajanet, A., see Abdelnour, C. (2) 625–632
Galazzo, I.B., see Pievani, M. (3) 825–843
Gallagher, P., see O’Caoimh, R. (1) 123–133
Gallouj, K., see El Haj, M., (1) 285–291
Gamaldo, A.A., see Beydoun, M.A. (3) 813–824
Ganio, K., see Cardoso, B.R. (1) 183–193
Gao, F., see Wei, M. (3) 899–906
Gao, Q., see Rawtaer, I. (2) 603–611
Gao, S., see Li, W. (1) 29–36
Gao, Y., see Liu, L.-S. (3) 723–734
Gao, Y., see O’Caoimh, R. (1) 123–133
García-Alba, J., see Fenoll, R. (1) 61–70
García-Casal, J.A., M. Goñi-Imizcoz, M.V. Perea-Bartolomé, F. Soto-Pérez, S.J. Smith, S. Calvo-Simal and M. Franco-Martín, The Efficacy of Emotion Recognition Rehabilitation for People with Alzheimer’s Disease (3) 937–951
Garcia-Ptacek, S., see Kramberger, M.G. (3) 787–795
Gardini, S., see Barocco, F. (3) 775–786
Gass, A., see Ketter, N., (2) 557–573
Gazzina, S., S. Archetti, A. Alberici, E. Bonomi, M. Cosseddu, D. Di Lorenzo, A. Padovani and B. Borroni, Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation (4) 1185–1189
Genius, J., see van der Ven, A.T. (2) 531–540
Gervaise-Henry, C., G. Watfa, E. Albuisson, A. Kolodziej, B. Dousset, J.-L. Olivier, T.R. Jonveaux and C. Malaplate-Armand, Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting (2) 437–445
Ghribi, O., see Marwarha, G. (3) 907–925
Gill, D.P., see Gregory, M.A. (3) 747–763
Giménez, J., see Espinosa, A. (2) 447–459
Ginestroni, A., see Lombardi, G. (3) 697–703
Giuli, C., see Balietti, M. (1) 37–43
Giuliani, F., see D’Onofrio, G. (3) 927–935
Gobbi, M., see Romeo, M. (3) 857–871
Goldbourt, U., see Lutski, M. (2) 633–643
Goldbourt, U., see Ravona-Springer, R. (3) 873–883
Goñi-Imizcoz, M., see García-Casal, J.A. (3) 937–951
Gonzales, E.B. and N. Sumien, Acidity and Acid-Sensing Ion Channels in the Normal and Alzheimer’s Disease Brain (4) 1137–1144
González, A., see Riancho, J. (2) 483–491
Gore, J.C., see Monroe, T.B. (1) 71–83
Gorno-Tempini, M., see Riancho, J. (3) 717–721
Greco, A., see D’Onofrio, G. (3) 927–935
Gregory, M.A., N.C. Boa Sorte Silva, D.P. Gill, C.L. McGowan, T. Liu-Ambrose, J.K. Shoemaker, V. Hachinski, J. Holmes and R.J. Petrella, Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline (3) 747–763
Greve, D.N., see Lindemer, E.R. (1) 293–303
Griswold, M.E., see Meyer, M.L. (1) 195–204
Grothe, M.J., see Ochmann, S. (4) 1303–1313
Gu, Y., see Zhu, C.W. (1) 305–315
Güell-Bosch, J., see Esquerda-Canals, G. (4) 1171–1183
Guitart, M., see Abdelnour, C. (2) 625–632
Gunstad, J., see Alosco, M.L. (3) 953–968
Guo, L., J. Tian and H. Du, Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease (4) 1071–1086
Hachinski, V., see Gregory, M.A. (3) 747–763
Hagenaars, S.P., see Marioni, R.E. (1) 275–283
Hane, F.T., B.Y. Lee and Z. Leonenko, Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology (1) 1–28
Hane, F.T., M. Robinson, B.Y. Lee, O. Bai, Z. Leonenko and M.S. Albert, Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment (3) 645–665
Hane, F.T., see Robinson, M. (2) 317–330
Hanson, A.J., see Craft, S. (4) 1325–1334
Happich, M., see Reed, C. (3) 797–812
Hare, D.J., see Cardoso, B.R. (1) 183–193
Haro, J.M., see Reed, C. (3) 797–812
Harrington, K., see Hollands, S. (2) 411–422
Harvey, P.D., see Czaja, S.J. (4) 1229–1238
Hatashita, S. and D. Wakebe, Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer’s Disease Defined with Amyloid PET Imaging (3) 765–773
Hattori, N., see Nakayama, S. (1) 267–273
Hauenstein, K., see Ochmann, S. (4) 1303–1313
Hayward, C., see Marioni, R.E. (1) 275–283
He, N.-Y., see Liu, L.-S. (3) 723–734
Heinsen, H., see Rüb, U. (3) 683–696
Heiss, G., see Meyer, M.L. (1) 195–204
Hendrix, S.B., see Espinosa, A. (2) 447–459
Herman, D., see van der Ven, A.T. (2) 531–540
Hernández, I., see Abdelnour, C. (2) 625–632
Hernández, I., see Espinosa, A. (2) 447–459
Heuer, E., J. Jacobs, R. Du, S. Wang, O.P. Keifer Jr., A.F. Cintron, J. Dooyema, Y. Meng, X. Zhang and L.C. Walker, Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy (2) 519–530
Hollands, S., Y.Y. Lim, S.M. Laws, V.L. Villemagne, R.H. Pietrzak, K. Harrington, T. Porter, P. Snyder, D. Ames, C. Fowler, S.R. Rainey-Smith, R.N. Martins, O. Salvado, J. Robertson, C.C. Rowe, C.L. Masters and P. Maruff for the AIBL Research Group, APOE e4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults (2) 411–422
Holmes, J., see Gregory, M.A. (3) 747–763
Hong, Y., see Yu, L. (2) 475–482
Hortobágyi, T., see Alghamdi, A. (2) 373–386
Howlett, D.R., see Alghamdi, A. (2) 373–386
Hrdlicka, L.A., see Mehta, P.D. (1) 135–145
Huang, C.-C. and C. Isidoro, Raman Spectrometric Detection Methods for Early and Non-Invasive Diagnosis of Alzheimer’s Disease (4) 1145–1156
Huang, E., see Li, W. (1) 29–36
Huang, H.-c., see Liu, X.-j. (4) 1157–1170
Huang, Y., W. Shen, J. Su, B. Cheng, D. Li, G. Liu, W.-X. Zhou and Y.-X. Zhang, Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity (3) 885–897
Humann, S.R., see Rhea, E.M. (1) 241–252
Humpel, C., see Oberacher, H. (2) 493–504
Huo, K., see Wei, M. (3) 899–906
Hussey, E.P., see Mason, E.J. (3) 735–745
Ibarria, M., see Espinosa, A. (2) 447–459
Iga, J.-i., see Yamazaki, K. (1) 171–181
Ikeda, M., see Shinagawa, S. (4) 1221–1227
Ikram, M.A., see Wingbermühle, R. (4) 1191–1195
Ikram, M.K., see Bouvy, W.H. (3) 705–710
Insausti, R., see Delgado-González, J.-C. (2) 461–473
Isidoro, C., see Huang, C.-C. (4) 1145–1156
Isserles, M., Z.J. Daskalakis, S. Kumar, T.K. Rajji and D.M. Blumberger, Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia (1) 45–51
Iwata, N., see Kishi, T. (1) 113–121
Jacobs, J., see Heuer, E. (2) 519–530
Jacqueline, S., see Rouch, I. (1) 147–155
Jang, Y.K., see Kim, H.J. (3) 711–716
Jha, N.K., see Jha, S.K. (4) 1017–1039
Jha, S.K., N.K. Jha, D. Kumar, R. Sharma, A. Shrivastava, R.K. Ambasta and P. Kumar, Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets? (4) 1017–1039
Jia, J., see Dong, J. (2) 613–623
Jiang, S. and K. Bhaskar, Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer’s Disease (4) 1123–1135
Jiang, Y., see Wei, M. (3) 899–906
Jiang, Y., see Yu, L. (2) 475–482
Jin, T., see Li, Y. (2) 395–409
Jones, R.W., see Reed, C. (3) 797–812
Jonveaux, T.R., see Gervaise-Henry, C. (2) 437–445
José, I.S., see Espinosa, A. (2) 447–459
Jun, S., see Kim, H.J. (3) 711–716
Jung, Y., see Craft, S. (4) 1325–1334
Kamimura, N., see Shinagawa, S. (4) 1221–1227
Kandimalla, R. and P.H. Reddy, Therapeutics of Neurotransmitters in Alzheimer’s Disease (4) 1049–1069
Kapp, E.A., see Cardoso, B.R. (1) 183–193
Kappelle, L.J., see Bouvy, W.H. (3) 705–710
Kasper, E., see Brueggen, K. (4) 1315–1324
Kasper, E., see Ochmann, S. (4) 1303–1313
Kazimierczak, M., see Riancho, J. (2) 483–491
Kazui, H., see Shinagawa, S. (4) 1221–1227
Keifer Jr., O.P., see Heuer, E. (2) 519–530
Kenny, R.-A., see O’Hare, C. (4) 1239–1250
Ketter, N., H.R. Brashear, J. Bogert, J. Di, Y. Miaux, A. Gass, D.D. Purcell, F. Barkhof and H.M. Arrighi, Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients (2) 557–573
Kida, H., see Satoh, M. (1) 85–96
Kim, H.J., H. Cho, D.J. Werring, Y.K. Jang, Y.J. Kim, J.S. Lee, J. Lee, S. Jun, S. Park, Y.H. Ryu, J.Y. Choi, Y.S. Cho, S.H. Moon, D.L. Na, C.H. Lyoo and S.W. Seo, 18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy (3) 711–716
Kim, Y.J., see Kim, H.J. (3) 711–716
Kishi, T., S. Matsunaga and N. Iwata, A Meta-Analysis of Memantine for Depression (1) 113–121
Kleinjan, M., see Marwarha, G. (3) 907–925
Knopman, D.S., see Meyer, M.L. (1) 195–204
Ko, P.C., see Mason, E.J. (3) 735–745
Koek, H.L., see Bouvy, W.H. (3) 705–710
Kolodziej, A., see Gervaise-Henry, C. (2) 437–445
Korf, H.-W., see Rüb, U. (3) 683–696
Kowall, N.W., see Alosco, M.L. (3) 953–968
Kramberger, M.G., B. Auestad, S. Garcia-Ptacek, C. Abdelnour, J.G. Olmo, Z. Walker, A.W. Lemstra, E. Londos, F. Blanc, L. Bonanni, I. McKeith, B. Winblad, F.J. de Jong, F. Nobili, E. Stefanova, M. Petrova, C. Falup-Pecurariu, I. Rektorova, S. Bostantjopoulou, R. Biundo, D. Weintraub and D. Aarsland on behalf of the E-DLB, Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort (3) 787–795
Krishnamani, P., see Amen, D.G. (1) 253–266
Krolak-Salmon, P., see Rouch, I. (1) 147–155
Kuijf, H.J., see Bouvy, W.H. (3) 705–710
Kumar, D., see Jha, S.K. (4) 1017–1039
Kumar, P., see Jha, S.K. (4) 1017–1039
Kumar, S., see Isserles, M. (1) 45–51
Lafuente, A., see Espinosa, A. (2) 447–459
Lage, C., see Riancho, J. (2) 483–491
Lage, C., see Riancho, J. (3) 717–721
Lambracht-Washington, D., M. Fu, M. Wight-Carter, M. Riegel and R.N. Rosenberg, Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer (1) 97–112
Landau, S.M., see Espinosa, A. (2) 447–459
Lao, F.-x., see Liu, X.-j. (4) 1157–1170
Launer, L., see O’Hare, C. (4) 1239–1250
Laurent, B., see Rouch, I. (1) 147–155
Laws, S.M., see Hollands, S. (2) 411–422
Lee, B.Y., see Hane, F.T. (1) 1–28
Lee, B.Y., see Hane, F.T. (3) 645–665
Lee, B.Y., see Robinson, M. (2) 317–330
Lee, J., see Kim, H.J. (3) 711–716
Lee, J.S., see Kim, H.J. (3) 711–716
Lee, T.-S., see Rawtaer, I. (2) 603–611
Lemstra, A.W., see Kramberger, M.G. (3) 787–795
Leonenko, Z., see Hane, F.T. (1) 1–28
Leonenko, Z., see Hane, F.T. (3) 645–665
Li, D., see Huang, Y. (3) 885–897
Li, F., see Wang, J. (1) 227–240
Li, J., see Yin, H. (4) 1207–1220
Li, Q., see Liu, L.-S. (3) 723–734
Li, Q.-X., see Cardoso, B.R. (1) 183–193
Li, W., E. Huang and S. Gao, Type 1 Diabetes Mellitus and Cognitive Impairments: A Systematic Review (1) 29–36
Li, Y., see Dorey, E. (4) 1265–1279
Li, Y., see Wei, M. (3) 899–906
Li, Y., Z.-X. Li, T. Jin, Z.-Y. Wang and P. Zhao, Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases (2) 395–409
Li, Z.-X., see Li, Y. (2) 395–409
Lilek, J., see Marwarha, G. (3) 907–925
Lim, W.S., see Rawtaer, I. (2) 603–611
Lim, Y.Y., see Hollands, S. (2) 411–422
Lindemer, E.R., D.N. Greve, B. Fischl, J.C. Augustinack and D.H. Salat for the Alzheimer’s Disease Neu-roimaging Initiative, Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer’s Disease (1) 293–303
Linhart, C., see Oberacher, H. (2) 493–504
Liu, F., see Wang, J. (1) 227–240
Liu, G., see Huang, Y. (3) 885–897
Liu, G., see Wang, J. (1) 227–240
Liu, H., see Dorey, E. (4) 1265–1279
Liu, J., see Wei, M. (3) 899–906
Liu, L.-S., X.-Q. Bai, Y. Gao, Q. Wu, Z. Ren, Q. Li, L.-H. Pan, N.-Y. He, J. Peng and Z.-H. Tang, PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway (3) 723–734
Liu, X.-j., J. Wei, Y.-h. Shang, H.-c. Huang and F.-x. Lao, Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer’s Disease (4) 1157–1170
Liu, Y., see Wang, J. (1) 227–240
Liu-Ambrose, T., see Gregory, M.A. (3) 747–763
Lleó, A., see Riancho, J. (2) 483–491
Loewenstein, D.A., see Czaja, S.J. (4) 1229–1238
Lombardi, G., V. Berti, A. Tedde, S. Bagnoli, I. Piaceri, C. Polito, G. Lucidi, C. Ferrari, A. Ginestroni, M. Moretti, A. Pupi, B. Nacmias and S. Sorbi, Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier (3) 697–703
Londos, E., see Kramberger, M.G. (3) 787–795
Lopez-Font, I., C.P. Boix, H. Zetterberg, K. Blennow and J. Sáez-Valero, Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer’s Disease Patients (4) 1281–1291
Lothian, A., see Cardoso, B.R. (1) 183–193
Lucidi, G., see Lombardi, G. (3) 697–703
Lue, L.-F., see Dorey, E. (4) 1265–1279
Luijten, P.R., see Bouvy, W.H. (3) 705–710
Lutski, M., G. Weinstein, U. Goldbourt and D. Tanne, Insulin Resistance and Future Cognitive Performance and Cognitive Decline in Elderly Patients with Cardiovascular Disease (2) 633–643
Lyoo, C.H., see Kim, H.J. (3) 711–716
Ma, L., see Wei, M. (3) 899–906
Malaplate-Armand, C., see Gervaise-Henry, C. (2) 437–445
Maldjian, J., see Craft, S. (4) 1325–1334
Mandy, W., see Stott, J. (4) 1293–1302
Manenti, R., see Pievani, M. (3) 825–843
Mansilla-Legorburo, F., see Delgado-González, J.-C. (2) 461–473
Mao, C., see Yang, J. (1) 157–169
Marioni, R.E., A. Campbell, S.P. Hagenaars, R. Nagy, C. Amador, C. Hayward, D.J. Porteous, P.M. Visscher and I.J. Deary, Genetic Stratification to Identify Risk Groups for Alzheimer’s Disease (1) 275–283
Marksteiner, J., see Oberacher, H. (2) 493–504
Martin, B., see Alosco, M.L. (3) 953–968
Martínez-Lage, P., see Espinosa, A. (2) 447–459
Martínez-Rodriguez, I., see Riancho, J. (3) 717–721
Martínez-Vilavella, G., see Fenoll, R. (1) 61–70
Martin-Gaujard, G., see Rouch, I. (1) 147–155
Martins, R.N., see Cardoso, B.R. (1) 183–193
Martins, R.N., see Hollands, S. (2) 411–422
Maruff, P., see Hollands, S. (2) 411–422
Marwarha, G., S. Rostad, J. Lilek, M. Kleinjan, J. Schommer and O. Ghribi, Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation (3) 907–925
Mason, E.J., E.P. Hussey, R.J. Molitor, P.C. Ko, M.J. Donahue and B.A. Ally, Family History of Alzheimer’s Disease is Associated with Impaired Perceptual Discrimination of Novel Objects (3) 735–745
Masters, C.L., see Cardoso, B.R. (1) 183–193
Masters, C.L., see Hollands, S. (2) 411–422
Matías-Guiu, J., see Fernández-Matarrubia, M. (4) 1251–1264
Matías-Guiu, J.A., see Fernández-Matarrubia, M. (4) 1251–1264
Matsunaga, S., see Kishi, T. (1) 113–121
Mauleón, A., see Abdelnour, C. (2) 625–632
Mazur-Kolecka, B., see Mehta, P.D. (1) 135–145
McGowan, C.L., see Gregory, M.A. (3) 747–763
McKee, A.C., see Alosco, M.L. (3) 953–968
McKeith, I., see Kramberger, M.G. (3) 787–795
Mehta, P.D., J.-F. Blain, E.A. Freeman, B.A. Patrick, M. Barshatzky, L.A. Hrdlicka, S.P. Mehta, J. Frackowiak, B. Mazur-Kolecka, J. Wegiel, H. Patzke and D.L. Miller, Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amy-loid-β Peptide 1–37 (Aβ37) (1) 135–145
Mehta, S.P., see Mehta, P.D. (1) 135–145
Mendez, M.F., What is the Relationship of Traumatic Brain Injury to Dementia? (3) 667–681
Meneghello, F., see De Marco, M. (2) 541–556
Meng, Y., see Heuer, E. (2) 519–530
Meyer, M.L., P. Palta, H. Tanaka, J.A. Deal, J. Wright, D.S. Knopman, M.E. Griswold, T.H. Mosley and G. Heiss, Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS) (1) 195–204
Meysami, S., see Amen, D.G. (1) 253–266
Miaux, Y., see Ketter, N., (2) 557–573
Miller, D.L., see Mehta, P.D. (1) 135–145
Molitor, R.J., see Mason, E.J. (3) 735–745
Molloy, D.W., see O’Caoimh, R. (1) 123–133
Monroe, T.B., P.A. Beach, S.P. Bruehl, M.S. Dietrich, B.P. Rogers, J.C. Gore, S.W. Atalla and R.L. Cowan, The Impact of Alzheimer’s Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study (1) 71–83
Montine, T.J., see Craft, S. (4) 1325–1334
Montoliu-Gaya, L., see Esquerda-Canals, G. (4) 1171–1183
Moon, S.H., see Kim, H.J. (3) 711–716
Moreno-Grau, S., see Abdelnour, C. (2) 625–632
Moreno-Ramos, T., see Fernández-Matarrubia, M. (4) 1251–1264
Moretti, M., see Lombardi, G. (3) 697–703
Mori, T., see Shinagawa, S. (4) 1221–1227
Mori, T., see Yamazaki, K. (1) 171–181
Mori, Y., see Yamazaki, K. (1) 171–181
Morley, J.E., see Rhea, E.M. (1) 241–252
Mosley, T.H., see Meyer, M.L. (1) 195–204
Mößner, R., see van der Ven, A.T. (2) 531–540
Motoi, Y., see Nakayama, S. (1) 267–273
Mouchoux, C., see Rouch, I. (1) 147–155
Mukherjee, S., see Cardoso, B.R. (1) 183–193
Munuera, J., see Espinosa, A. (2) 447–459
Na, D.L., see Kim, H.J. (3) 711–716
Nacmias, B., see Lombardi, G. (3) 697–703
Nagy, R., see Marioni, R.E. (1) 275–283
Najem, D., see Dorey, E. (4) 1265–1279
Nakaguchi, N., see Satoh, M. (1) 85–96
Nakanishi, A., see Nakayama, S. (1) 267–273
Nakao, K., see Satoh, M. (1) 85–96
Nakayama, K., see Shinagawa, S. (4) 1221–1227
Nakayama, S., A. Suda, A. Nakanishi, Y. Motoi and N. Hattori, Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer’s Disease (1) 267–273
Neth, B., see Craft, S. (4) 1325–1334
Newberg, A., see Amen, D.G. (1) 253–266
Newman, A., see O’Hare, C. (4) 1239–1250
Ng, T.P., see Rawtaer, I. (2) 603–611
Ni, M., see Wang, J. (1) 227–240
Nielson, K.A., see Chirles, T.J. (3) 845–856
Nirkhe, S., see Rhea, E.M. (1) 241–252
Nobili, F., see Kramberger, M.G. (3) 787–795
Novell-Alsina, R., see Fenoll, R. (1) 61–70
Nyunt, M.S.Z., see Rawtaer, I. (2) 603–611
O’Brien, J.T., see Alghamdi, A. (2) 373–386
O’Caoimh, R., Y. Gao, A. Svendovski, P. Gallagher, J. Eustace and D.W. Molloy, Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia (1) 123–133
O’Hare, C., R.-A. Kenny, H. Aizenstein, R. Boudreau, A. Newman, L. Launer, S. Satterfield, K. Yaffe and C. Rosano for the Health ABC Study, Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults (4) 1239–1250
Oberacher, H., K. Arnhard, C. Linhart, A. Diwo, J. Marksteiner and C. Humpel, Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool? (2) 493–504
Ochi, S., see Yamazaki, K. (1) 171–181
Ochmann, S., M. Dyrba, M.J. Grothe, E. Kasper, S. Webel, K. Hauenstein and S.J. Teipel, Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer’s Disease? An Interventional Study (4) 1303–1313
Ochmann, S., see Brueggen, K. (4) 1315–1324
Ogawa, J.-i., see Satoh, M. (1) 85–96
Olivier, J.-L., see Gervaise-Henry, C. (2) 437–445
Olmo, J.G., see Kramberger, M.G. (3) 787–795
Ornstein, K.A., see Zhu, C.W. (1) 305–315
Ortega, G., see Abdelnour, C. (2) 625–632
Ozaki, Y., see Yamazaki, K. (1) 171–181
Padovani, A., see Gazzina, S. (4) 1185–1189
Palta, P., see Meyer, M.L. (1) 195–204
Pan, L.-H., see Liu, L.-S. (3) 723–734
Pang, W., see Yu, L. (2) 475–482
Panza, F., see D’Onofrio, G. (3) 927–935
Papa, R., see Balietti, M. (1) 37–43
Pape, J.C., see van der Ven, A.T. (2) 531–540
Park, S., see Kim, H.J. (3) 711–716
Patrick, B.A., see Mehta, P.D. (1) 135–145
Patzke, H., see Mehta, P.D. (1) 135–145
Pelosi, A., see Barocco, F. (3) 775–786
Peña-Ortega, F., see Salgado-Puga, K. (1) 205–226
Peng, J., see Liu, L.-S. (3) 723–734
Perea-Bartolomé, M.V., see García-Casal, J.A. (3) 937–951
Pérez-Cordón, A., see Abdelnour, C. (2) 625–632
Pesini, P., see Espinosa, A. (2) 447–459
Petrella, R.J., see Gregory, M.A. (3) 747–763
Petrova, M., see Kramberger, M.G. (3) 787–795
Pfaff, H., see Brueggen, K. (4) 1315–1324
Piaceri, I., see Lombardi, G. (3) 697–703
Pietrzak, R.H., see Hollands, S. (2) 411–422
Pievani, M., L. Pini, C. Ferrari, F.B. Pizzini, I.B. Galazzo, C. Cobelli, M. Cotelli, R. Manenti and G.B. Frisoni, Coordinate-Based Meta-Analysis of the Default Mode and Salience Network for Target Identification in Non-Invasive Brain Stimulation of Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia Networks (3) 825–843
Pini, L., see Pievani, M. (3) 825–843
Pizzini, F.B., see Pievani, M. (3) 825–843
Polito, C., see Lombardi, G. (3) 697–703
Pongan, E., see Rouch, I. (1) 147–155
Porteous, D.J., see Marioni, R.E. (1) 275–283
Porter, T., see Hollands, S. (2) 411–422
Postacchini, D., see Balietti, M. (1) 37–43
Potvin, O., see Dallaire-Théroux, C. (2) 575–601
Pozueta, A., see Riancho, J. (2) 483–491
Pozueta, A., see Riancho, J. (3) 717–721
Prado-Alcalá, R.A., see Salgado-Puga, K. (1) 205–226
Price, J., see Anstey, K.J. (4) 1197–1205
Pujadas, F., see Espinosa, A. (2) 447–459
Pujol, J., see Fenoll, R. (1) 61–70
Pupi, A., see Lombardi, G. (3) 697–703
Purcell, D.D., see Ketter, N., (2) 557–573
Qiao, S., see Wang, J. (1) 227–240
Qin, W., see Dong, J. (2) 613–623
Qu, Q., see Wei, M. (3) 899–906
Rainey-Smith, S.R., see Hollands, S. (2) 411–422
Raji, C.A., see Amen, D.G. (1) 253–266
Rajji, T.K., see Isserles, M. (1) 45–51
Rajmohan, R. and P.H. Reddy, Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons (4) 975–999
Ravona-Springer, R., M. Schnaider-Beeri and U. Goldbourt, Triceps and Subscapular Skinfold in Men Aged 40–65 and Dementia Prevalence 36 Years Later (3) 873–883
Rawtaer, I., Q. Gao, M.S.Z. Nyunt, L. Feng, M.S. Chong, W.S. Lim, T.-S. Lee, P. Yap, K.B. Yap and T.P. Ng, Psychosocial Risk and Protective Factors and Incident Mild Cognitive Impairment and Dementia in Community Dwelling Elderly: Findings from the Singapore Longitudinal Ageing Study (2) 603–611
Reddy, A.P., see Bethea, C.L. (4) 1001–1015
Reddy, P.H., A Critical Assessment of Research on Neurotransmitters in Alzheimer’s Disease (4) 969–974
Reddy, P.H., see Kandimalla, R. (4) 1049–1069
Reddy, P.H., see Rajmohan, R. (4) 975–999
Reddy, P.H., see Wang, R. (4) 1041–1048
Reed, C., M. Happich, J.M. Argimon, J.M. Haro, A. Wimo, G. Bruno, R. Dodel, R.W. Jones, B. Vellas and M. Belger, What Drives Country Differences in Cost of Alzheimer’s Disease? An Explanation from Resource Use in the GERAS Study (3) 797–812
Reiter, K., see Chirles, T.J. (3) 845–856
Rektorova, I., see Kramberger, M.G. (3) 787–795
Ren, Z., see Liu, L.-S. (3) 723–734
Rhea, E.M., S.R. Humann, S. Nirkhe, S.A. Farr, J.E. Morley and W.A. Banks, Intranasal Insulin Transport is Pre-served in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition (1) 241–252
Riancho, J., A. Pozueta, M. Santos, C. Lage, J.M. Carril, I. Banzo, I. Martínez-Rodriguez, M. Gorno-Tempini and P. Sánchez-Juan, Logopenic Aphasia due to a Strategic Stroke: New Evidence from a Single Case (3) 717–721
Riancho, J., J.L. Vázquez-Higuera, A. Pozueta, C. Lage, M. Kazimierczak, M. Bravo, M. Calero, A. González, E. Rodríguez, A. Lleó and P. Sánchez-Juan, MicroRNA Profile in Patients with Alzheimer’s Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples (2) 483–491
Ribas-Vidal, N., see Fenoll, R. (1) 61–70
Ricciardi, F., see D’Onofrio, G. (3) 927–935
Riegel, M., see Lambracht-Washington, D. (1) 97–112
Roberts, B.R., see Cardoso, B.R. (1) 183–193
Robertson, J., see Hollands, S. (2) 411–422
Robinson, M., B.Y. Lee and F.T. Hane, Recent Progress in Alzheimer’s Disease Research, Part 2: Genetics and Epidemiology (2) 317–330
Robinson, M., see Hane, F.T. (3) 645–665
Rodríguez, E., see Riancho, J. (2) 483–491
Rodríguez-Colorado, J., see Salgado-Puga, K. (1) 205–226
Rodríguez-Gómez, O., see Abdelnour, C. (2) 625–632
Rogers, B.P., see Monroe, T.B. (1) 71–83
Romeo, M., M. Stravalaci, M. Beeg, A. Rossi, F. Fiordaliso, A. Corbelli, M. Salmona, M. Gobbi, A. Cagnotto and L. Diomede, Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity (3) 857–871
Rosano, C., see O’Hare, C. (4) 1239–1250
Rosenberg, R.N., see Lambracht-Washington, D. (1) 97–112
Rosende-Roca, M., see Abdelnour, C. (2) 625–632
Rossi, A., see Romeo, M. (3) 857–871
Rostad, S., see Marwarha, G. (3) 907–925
Rouch, I., E. Pongan, B. Trombert, F. Fabre, N. Auguste, C. Sellier, M. Freulon, S. Jacqueline, D. Federico, C. Mouchoux, G. Martin-Gaujard, P. Krolak-Salmon, B. Laurent and J.-M. Dorey, One-Year Evolution of Behavioral and Psychological Symptoms of Dementia in Patients Initially Hospitalized in Cognitive Behavioral Units: The EVITAL Prospective Cohort (1) 147–155
Rowe, C.C., see Hollands, S. (2) 411–422
Rüb, U., K. Stratmann, H. Heinsen, K. Seidel, M. Bouzrou and H.-W. Korf, Alzheimer’s Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches (3) 683–696
Ruiz, A., see Abdelnour, C. (2) 625–632
Ruiz, A., see Espinosa, A. (2) 447–459
Ruiz, S., see Espinosa, A. (2) 447–459
Rujescu, D., see van der Ven, A.T. (2) 531–540
Ryu, Y.H., see Kim, H.J. (3) 711–716
Sabbag, S.A., see Czaja, S.J. (4) 1229–1238
Sáez-Valero, J., see Lopez-Font, I. (4) 1281–1291
Saikali, S., see Dallaire-Théroux, C. (2) 575–601
Salat, D.H., see Lindemer, E.R. (1) 293–303
Salgado-Puga, K., J. Rodríguez-Colorado, R.A. Prado-Alcalá and F. Peña-Ortega, Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amy-loid-β (1) 205–226
Salmona, M., see Romeo, M. (3) 857–871
Salvado, O., see Hollands, S. (2) 411–422
Sanabria, Á., see Abdelnour, C. (2) 625–632
Sancarlo, D., see D’Onofrio, G. (3) 927–935
Sánchez, D., see Abdelnour, C. (2) 625–632
Sánchez-Benavides, G., see Fenoll, R. (1) 61–70
Sánchez-Juan, P., see Riancho, J. (2) 483–491
Sánchez-Juan, P., see Riancho, J. (3) 717–721
Sanin, G. and T. Benke, Bimanual Gesture Imitation in Alzheimer’s Disease (1) 53–59
Santos, M., see Riancho, J. (3) 717–721
Sao, T., see Yamazaki, K. (1) 171–181
Sarasa, M., see Espinosa, A. (2) 447–459
Satoh, M., J.-i. Ogawa, T. Tokita, N. Nakaguchi, K. Nakao, H. Kida and H. Tomimoto, Physical Exercise with Music Maintains Activities of Daily Living in Patients with Dementia: Mihama-Kiho Project Part 2 (1) 85–96
Satterfield, S., see O’Hare, C. (4) 1239–1250
Scherbaum, N., see van der Ven, A.T. (2) 531–540
Schloesser, R., see van der Ven, A.T. (2) 531–540
Schnaider-Beeri, M., see Ravona-Springer, R. (3) 873–883
Schneider, W., see Brueggen, K. (4) 1315–1324
Schommer, J., see Marwarha, G. (3) 907–925
Scior, K., see Stott, J. (4) 1293–1302
see Czaja, S.J. (4) 1229–1238 Crocco, E.,
Seidel, K., see Rüb, U. (3) 683–696
Sellier, C., see Rouch, I. (1) 147–155
Seo, S.W., see Kim, H.J. (3) 711–716
Seripa, D., see D’Onofrio, G. (3) 927–935
Shaked, D., see Beydoun, M.A. (3) 813–824
Shang, S., see Wei, M. (3) 899–906
Shang, Y.-h., see Liu, X.-j. (4) 1157–1170
Sharma, R., see Jha, S.K. (4) 1017–1039
Shen, W., see Huang, Y. (3) 885–897
Shen, Y., see Zhang, C. (2) 505–518
Shi, C., see Yang, J. (1) 157–169
Shigenobu, K., see Shinagawa, S. (4) 1221–1227
Shinagawa, S., K. Shigenobu, K. Tagai, R. Fukuhara, N. Kamimura, T. Mori, K. Yoshiyama, H. Kazui, K. Nakayama and M. Ikeda, Violation of Laws in Frontotemporal Dementia: A Multicenter Study in Japan (4) 1221–1227
Shoemaker, J.K., see Gregory, M.A. (3) 747–763
Shrivastava, A., see Jha, S.K. (4) 1017–1039
Smith, J.C., see Chirles, T.J. (3) 845–856
Smith, S.J., see García-Casal, J.A. (3) 937–951
Snyder, P., see Hollands, S. (2) 411–422
Sorbi, S., see Lombardi, G. (3) 697–703
Sotolongo-Grau, Ó., see Abdelnour, C. (2) 625–632
Sotolongo-Grau, O., see Espinosa, A. (2) 447–459
Soto-Pérez, F., see García-Casal, J.A. (3) 937–951
Spallazzi, M., see Barocco, F. (3) 775–786
Stanimirovic, D., see Dorey, E. (4) 1265–1279
Stefanova, E., see Kramberger, M.G. (3) 787–795
Stern, R.A., see Alosco, M.L. (3) 953–968
Stern, Y., see Zhu, C.W. (1) 305–315
Stott, J., K. Scior, W. Mandy and G. Charlesworth, Dementia Screening Accuracy is Robust to Premorbid IQ Variation: Evidence from the Addenbrooke’s Cognitive Examination-III and the Test of Premorbid Function (4) 1293–1302
Stratmann, K., see Rüb, U. (3) 683–696
Stravalaci, M., see Romeo, M. (3) 857–871
Su, J., see Huang, Y. (3) 885–897
Suda, A., see Nakayama, S. (1) 267–273
Sumien, N., see Gonzales, E.B. (4) 1137–1144
Suo, Z., see Yang, J. (1) 157–169
Svendovski, A., see O’Caoimh, R. (1) 123–133
Tagai, K., see Shinagawa, S. (4) 1221–1227
Tammineni, P., see Cai, Q. (4) 1087–1103
Tanaka, H., see Meyer, M.L. (1) 195–204
Tang, Y., see Dong, J. (2) 613–623
Tang, Z.-H., see Liu, L.-S. (3) 723–734
Tanne, D., see Lutski, M. (2) 633–643
Tárraga, L., see Abdelnour, C. (2) 625–632
Tárraga, L., see Espinosa, A. (2) 447–459
Tedde, A., see Lombardi, G. (3) 697–703
Teipel, S., see Brueggen, K. (4) 1315–1324
Teipel, S.J., see Ochmann, S. (4) 1303–1313
Tejero, M.A., see Espinosa, A. (2) 447–459
Thomas, A.J., see Alghamdi, A. (2) 373–386
Tian, J., see Guo, L. (4) 1071–1086
Toepper, M., Dissociating Normal Aging from Alzheimer’s Disease: A View from Cognitive Neuroscience (2) 331–352
Tokita, T., see Satoh, M. (1) 85–96
Tomimoto, H., see Satoh, M. (1) 85–96
Tönnies, E. and E. Trushina, Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease (4) 1105–1121
Torp, R., see Yang, J. (1) 157–169
Tripodis, Y., see Alosco, M.L. (3) 953–968
Trittschuh, E.H., see Craft, S. (4) 1325–1334
Trombert, B., see Rouch, I. (1) 147–155
Trushina, E., see Tönnies, E. (4) 1105–1121
Ueno, S.-i., see Yamazaki, K. (1) 171–181
Valero, S., see Abdelnour, C. (2) 625–632
Valero, S., see Espinosa, A. (2) 447–459
Valles-Salgado, M., see Fernández-Matarrubia, M. (4) 1251–1264
Vallortigara, J., see Alghamdi, A. (2) 373–386
van der Ven, A.T., J.C. Pape, D. Herman, R. Schloesser, J. Genius, N. Fischer, R. Mößner, N. Scherbaum, J. Wiltfang, D. Rujescu and J. Benninghoff, Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer’s Disease (2) 531–540
Vargas, L., see Abdelnour, C. (2) 625–632
Vázquez-Higuera, J.L., see Riancho, J. (2) 483–491
Vellas, B., see Reed, C. (3) 797–812
Venneri, A., see De Marco, M. (2) 541–556
Villegas, S., see Esquerda-Canals, G. (4) 1171–1183
Villemagne, V.L., see Hollands, S. (2) 411–422
Visscher, P.M., see Marioni, R.E. (1) 275–283
Wakebe, D., see Hatashita, S. (3) 765–773
Walker, D., see Dorey, E. (4) 1265–1279
Walker, L.C., see Heuer, E. (2) 519–530
Walker, Z., see Kramberger, M.G. (3) 787–795
Wang, J., Y. Liu, X. Cheng, X. Zhang, F. Liu, G. Liu, S. Qiao, M. Ni, W. Zhou, Y. Zhang and F. Li, The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer’s Disease (1) 227–240
Wang, L., see Yin, H. (4) 1207–1220
Wang, Q., see Dong, J. (2) 613–623
Wang, R. and P.H. Reddy, Role of Glutamate and NMDA Receptors in Alzheimer’s Disease (4) 1041–1048
Wang, S., see Heuer, E. (2) 519–530
Wang, W., see Yin, H. (4) 1207–1220
Wang, W., see Yu, L. (2) 475–482
Wang, X., see Yin, H. (4) 1207–1220
Wang, Z.-Y., see Li, Y. (2) 395–409
Watfa, G., see Gervaise-Henry, C. (2) 437–445
Webel, S., see Brueggen, K. (4) 1315–1324
Webel, S., see Ochmann, S. (4) 1303–1313
Wegiel, J., see Mehta, P.D. (1) 135–145
Wei, C., see Dong, J. (2) 613–623
Wei, J., see Liu, X.-j. (4) 1157–1170
Wei, M., B. Zhao, K. Huo, Y. Deng, S. Shang, J. Liu, Y. Li, L. Ma, Y. Jiang, L. Dang, C. Chen, S. Wei, J. Zhang, H. Yang, F. Gao and Q. Qu, Sleep Deprivation Induced Plasma Amyloid-β Transport Disturbance in Healthy Young Adults (3) 899–906
Wei, S., see Wei, M. (3) 899–906
Weinstein, G., see Lutski, M. (2) 633–643
Weintraub, D., see Kramberger, M.G. (3) 787–795
Weiss, L.R., see Chirles, T.J. (3) 845–856
Wen, K.-x., see Wingbermühle, R. (4) 1191–1195
Werring, D.J., see Kim, H.J. (3) 711–716
Whitfield, D.R., see Alghamdi, A. (2) 373–386
Whitlow, C., see Craft, S. (4) 1325–1334
Wight-Carter, M., see Lambracht-Washington, D. (1) 97–112
Wiltfang, J., see van der Ven, A.T. (2) 531–540
Wimo, A., see Reed, C. (3) 797–812
Winblad, B., see Bloniecki, V. (2) 387–393
Winblad, B., see Kramberger, M.G. (3) 787–795
Wingbermühle, R., K.-x. Wen, F.J. Wolters, M.A. Ikram and D. Bos, Smoking, APOE Genotype, and Cognitive Decline: The Rotterdam Study (4) 1191–1195
Wolters, F.J., see Wingbermühle, R. (4) 1191–1195
Wood, J.M., see Anstey, K.J. (4) 1197–1205
Wright, J., see Meyer, M.L. (1) 195–204
Wu, Q., see Liu, L.-S. (3) 723–734
Xiao, Z., see Yu, L. (2) 475–482
Xie, Z., see Zhang, C. (2) 505–518
Xu, Y., see Yang, J. (1) 157–169
Yaffe, K., see O’Hare, C. (4) 1239–1250
Yamazaki, K., Y. Yoshino, T. Mori, T. Yoshida, Y. Ozaki, T. Sao, Y. Mori, S. Ochi, J.-i. Iga and S.-i. Ueno, Gene Expression and Methylation Analysis of ABCA7 in Patients with Alzheimer’s Disease (1) 171–181
Yang, H., see Wei, M. (3) 899–906
Yang, J., R. Zhang, C. Shi, C. Mao, Z. Yang, Z. Suo, R. Torp and Y. Xu, AQP4 Association with Amyloid Deposi-tion and Astrocyte Pathology in the Tg-ArcSwe Mouse Model of Alzheimer’s Disease (1) 157–169
Yang, Z., see Yang, J. (1) 157–169
Yap, K.B., see Rawtaer, I. (2) 603–611
Yap, P., see Rawtaer, I. (2) 603–611
Yin, H., W. Wang, W. Yu, J. Li, N. Feng, L. Wang and X. Wang, Changes in Synaptic Plasticity and Glutamate Receptors in Type 2 Diabetic KK-Ay Mice (4) 1207–1220
Yoshida, T., see Yamazaki, K. (1) 171–181
Yoshino, Y., see Yamazaki, K. (1) 171–181
Yoshiyama, K., see Shinagawa, S. (4) 1221–1227
Yu, L., W. Wang, W. Pang, Z. Xiao, Y. Jiang and Y. Hong, Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation (2) 475–482
Yu, W., see Yin, H. (4) 1207–1220
Zetterberg, H., see Lopez-Font, I. (4) 1281–1291
Zhang, C., Y. Zhang, Y. Shen, G. Zhao, Z. Xie and Y. Dong, Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer’s Disease Transgenic Mice (2) 505–518
Zhang, J., see Wei, M. (3) 899–906
Zhang, R., see Yang, J. (1) 157–169
Zhang, W., see Dorey, E. (4) 1265–1279
Zhang, X., see Heuer, E. (2) 519–530
Zhang, X., see Wang, J. (1) 227–240
Zhang, Y., see Wang, J. (1) 227–240
Zhang, Y., see Zhang, C. (2) 505–518
Zhang, Y.-X., see Huang, Y. (3) 885–897
Zhao, B., see Wei, M. (3) 899–906
Zhao, G., see Zhang, C. (2) 505–518
Zhao, P., see Li, Y. (2) 395–409
Zhou, W., see Wang, J. (1) 227–240
Zhou, W.-X., see Huang, Y. (3) 885–897
Zhu, C.W., S. Cosentino, K.A. Ornstein, Y. Gu, H. Andrews and Y. Stern, Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures (1) 305–315
Zonderman, A.B., see Beydoun, M.A. (3) 813–824
Zwanenburg, J.J.M., see Bouvy, W.H. (3) 705–710